温控单元在化学和生物制药工业担负了重要的使命,它能确保化学合成药物和生物药物生产的顺利进行,尤其是在新冠病毒疫苗未来的大规模量产中会发挥尤其重要的作用。在这些工艺中,最重要当属生物反应器的温度控制了。微生物组织需要非常稳定的温度下进行培养,如37到38°C ,然后需要快速冷却室温等温度再进行下一步的层析、过滤等工艺流程。“我们在生物制药领域,已经向众多国际著名的反应器和混合器和系统的集成商提供了优秀的温度控制产品,尤其是我们的Integral T 和Variocool制冷设备已基本成为行业的对标产品系列,秉承LAUDA优良的品质和技术,我们收到了广大用户的认可”。LAUDA公司CEO Gunther Wobser博士指出。
为了大规模的疫苗生产,我们的工业部门还提供了定制的加热和冷却系统,来满足放大生产的需求。这里面包含了制冷系统,又称“冻融”系统,在此系统中,培养物会被迅速冷冻到大型的存储罐中,再移动到下一个工序进行生产。“我们最近接到了美国主要的新冠疫苗开发客户对于此类系统的需求”公司 COO Marc Stricker 博士说。
Measures for the maintenance of business operations
The global situation regarding the coronavirus has changed dramatically and has reached unexpected proportions. Today, we have once again defined important measures within the company that also have an impact on our business operations. We have drawn up a plan that will keep our business operations going for as long as possible. However, there may be certain restrictions on accessibility.
We have decided that from 17 March 2020, all business trips from Germany to other countries will be prohibited. In addition, we will not receive any business visits from abroad from 17 March until further notice. We ask for your understanding. It is important to us to emphasize that the health of our employees is always our top priority.
Furthermore, we try to conduct our business in such a way that our customers are affected as little as possible. However, certain effects cannot be avoided due to the epidemic. We thank you for your understanding and are available to answer your questions.